Benefits Tirzepatide attaches to two different receptors in the brain (GLP-1 and GIP), unlike previous GLP-1 medications, which only attach to one
Scientific and institutional sources All figures and dates cited in this comparison are based on published clinical trials and the following official opinions, verified on May 8, 2026
As a D-amino acid peptide, FOXO4-DRI is costly to synthesize, and a wrong amino acid at the binding site can sharply cut activity
1mg = 1,000mcg (micrograms) 1g = 1,000mg = 1,000,000mcg Injectable doses typically use milligrams
For researchers investigating compounds like our BPC 157 Peptide, knowing you have a pure, stable, and accurately sequenced product is the bedrock of reliable data